Overview
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
Status:
Completed
Completed
Trial end date:
2023-10-27
2023-10-27
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is an observational study comparing perioperative quantitative EEG parameters between the conventional propofol/remifentanil and remimazolam/remifentanil. We aim to compare and analyze the differences in EEG patterns during the postoperative recovery in a group that underwent remimazolam and remifentanil-based total intravenous anesthesia(TIVA), in comparison to propofol and remifentanil-based TIVAPhase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Yonsei UniversityTreatments:
Propofol
Criteria
Inclusion Criteria:Patients aged 19 to 65 years who meet the American Society of Anesthesiologists (ASA)
physical status classification 1-3 and undergo laparoscopic cholecystectomy at Severance
Hospital.
Exclusion Criteria:
Pregnant women, individuals with arrhythmias, emergency surgeries, obesity (BMI > 30),
day-surgery, foreigners, and illiterate individuals.